Par Pharmaceutical, Inc. Announces Quarterly Conference Call
5/9/2013 6:20:07 AM
More...
|
Par Pharmaceutical, Inc. to Pay $45 Million to Resolve Criminal, Civil Charges
3/7/2013 6:58:34 AM
More...
|
Par Pharmaceutical, Inc. Begins Shipment of Rizatriptan Benzoate Tablets and Rizatriptan Benzoate Orally Disintegrating Tablets
1/3/2013 8:27:43 AM
More...
|
Par Pharmaceutical, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition by TPG
7/16/2012 10:25:42 AM
More...
|
GlaxoSmithKline (GSK) Partner Pronova BioPharma Wins Lovaza Patent Case Against Teva Pharmaceutical Industries Limited (TEVA) & Par Pharmaceutical, Inc.
5/31/2012 7:38:43 AM
More...
|
Activist Investor Pushes Par Pharmaceutical, Inc. to Consider Selling Itself
5/9/2012 6:52:33 AM
More...
|
Par Pharmaceutical, Inc. Begins Shipment of Generic Provigil®
4/6/2012 9:56:10 AM
More...
|
Horizon Pharma, Inc. Files Patent Infringement Lawsuit Against Par Pharmaceutical, Inc. for Filing an ANDA Against DUEXIS(R)
3/29/2012 6:42:54 AM
More...
|
Par Pharmaceutical, Inc. Completes Acquisition of Edict Pharmaceuticals
2/21/2012 9:31:00 AM
More...
|
IntelGenx Corp. Announces Development and Commercialization Agreement With Par Pharmaceutical, Inc.
12/21/2011 9:57:17 AM
More...
|
|